Niagen® is the patented form of nicotinamide riboside (NR), a direct precursor your body converts into NAD+. Now provider-supervised and injectable, and CLYR is among the first to offer it. Prescribed by a licensed US provider. Delivered to your door.
Injectable Niagen® is brand new to telehealth. CLYR secured early access, so you can start now, before it is widely available. Enrollment is limited while early supply ramps.
Among the first US telehealth platforms to offer Niagen® as an injection, not just a capsule.
The branded, patented form of nicotinamide riboside, the precursor your body turns into NAD+.
A licensed US provider confirms it is appropriate and sets your protocol before anything ships.
Niagen® is NR. Your body runs it up a short pathway into NAD+, the coenzyme behind cellular energy and the repair enzymes tied to healthy aging.
One simple offer: your first month plus two provider-authorized refills. No subscription, no auto-renew — each refill is one tap when you're ready.
Niagen® is the branded, patented form of nicotinamide riboside (NR), a B3-family molecule the body converts into NAD+, the coenzyme tied to cellular energy and the repair enzymes associated with healthy aging. NAD+ levels tend to decline with age, which is why precursors like NR have drawn interest. Human research is still developing.
Oral forms are broken down and diluted before much reaches the bloodstream. The injectable route is designed to bypass that limit. If you prefer the coenzyme itself, we also offer NAD+, and your provider can help you choose.
Tell us your energy and longevity goals in a short online visit.
A licensed U.S. provider confirms Niagen® is appropriate and sets your protocol.
Niagen® and supplies at your door, with refills on your schedule.
NAD precursors are temperature-sensitive, so your vial never rides in a plain padded envelope. Every order goes out cold-chain, packed in an insulated mailer with gel ice packs, so it lands at your door chilled and ready to refrigerate.
One clear rhythm: 50 units (50 mg) subcutaneously every 3 days, from day 1 through day 28 after the vial is first opened. Here is the full schedule, start to finish.
One vial covers the full cycle; use it within 28 days of the first puncture. Dosing shown is the standard protocol — your licensed provider sets and may adjust it for you.
Niagen® is the patented, branded form of nicotinamide riboside (NR), a precursor your body converts into NAD+. It is the studied NR ingredient many longevity programs are built around.
NAD+ is the coenzyme itself; Niagen® (NR) is a precursor the body converts into NAD+. We offer both, and your provider can help you choose the right fit.
Injectable Niagen® is new to telehealth. CLYR has early access, so enrollment is limited while supply ramps. Getting in now means you start before it is widely available.
It is a small subcutaneous injection. Some people notice mild warmth or flushing; going slowly helps. Your provider will show you how to administer it.
Every prescription comes from a licensed U.S. provider and is filled by a licensed U.S. pharmacy. CLYR is LegitScript certified and HIPAA compliant.
A short visit, a real provider, delivered to your door. Be one of the first on injectable Niagen®.
Claim early accessNiagen® (nicotinamide riboside) injections are a prescription wellness treatment provided only after review by a licensed provider; not everyone qualifies. This product is compounded; compounded medications are not FDA-approved and are not reviewed by the FDA for safety, efficacy, or quality before reaching patients. Rapid administration can cause transient flushing, warmth, or nausea, so it is given slowly. Avoid during pregnancy or breastfeeding unless your provider advises otherwise. Tell your provider about all medications and conditions. Individual results vary.
Niagen® is a registered trademark of Niagen Bioscience, Inc. CLYR Health is an independent telehealth platform and is not affiliated with, endorsed by, or sponsored by Niagen Bioscience, Inc.